• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceUROLOGIX TARGIS SYSTEM
Classification Namesystem, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy
Generic Namesystem, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy
Applicant
Urologix, LLC
14405 21st avenue n.
minneapolis, MN 55447-2000
PMA NumberP970008
Supplement NumberS023
Date Received01/09/2003
Decision Date07/07/2003
Product Code
MEQ[ Registered Establishments with MEQ ]
Advisory Committee Gastroenterology/Urology
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
APPROVAL FOR 1) THE RTU PLUS, A MODIFIED VERSION OF THE RECTAL THERMOSENSING UNIT (RTU), AND 2) LABELING CHANGES. THE RTU PLUS INCLUDES A DISPOSABLE BALLOON AND REUSABLE HANDLE, AND WILL BE AVAILABLE AS AN ALTERNATIVE TO THE EXISTING SINGLE USE RTU.
-
-